Cargando…
Prevalence of Phosphodiesterase-5 Inhibitor Use in the VHA in 2004 and 2005 Is Twice That of a Commercial Health Plan in 2001
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Academy of Managed Care Pharmacy
2006
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10438309/ https://www.ncbi.nlm.nih.gov/pubmed/17269850 http://dx.doi.org/10.18553/jmcp.2006.12.8.692 |
| _version_ | 1785092762999193600 |
|---|---|
| author | French, Dustin D. Margo, Curtis E. Campbell, Robert R. |
| author_facet | French, Dustin D. Margo, Curtis E. Campbell, Robert R. |
| author_sort | French, Dustin D. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10438309 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2006 |
| publisher | Academy of Managed Care Pharmacy |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104383092023-08-21 Prevalence of Phosphodiesterase-5 Inhibitor Use in the VHA in 2004 and 2005 Is Twice That of a Commercial Health Plan in 2001 French, Dustin D. Margo, Curtis E. Campbell, Robert R. J Manag Care Pharm Letters Academy of Managed Care Pharmacy 2006-10 /pmc/articles/PMC10438309/ /pubmed/17269850 http://dx.doi.org/10.18553/jmcp.2006.12.8.692 Text en Copyright © 2006, Academy of Managed Care Pharmacy. All rights reserved. https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits unrestricted use and redistribution provided that the original author and source are credited. |
| spellingShingle | Letters French, Dustin D. Margo, Curtis E. Campbell, Robert R. Prevalence of Phosphodiesterase-5 Inhibitor Use in the VHA in 2004 and 2005 Is Twice That of a Commercial Health Plan in 2001 |
| title | Prevalence of Phosphodiesterase-5 Inhibitor Use in the VHA in 2004 and 2005 Is Twice That of a Commercial Health Plan in 2001 |
| title_full | Prevalence of Phosphodiesterase-5 Inhibitor Use in the VHA in 2004 and 2005 Is Twice That of a Commercial Health Plan in 2001 |
| title_fullStr | Prevalence of Phosphodiesterase-5 Inhibitor Use in the VHA in 2004 and 2005 Is Twice That of a Commercial Health Plan in 2001 |
| title_full_unstemmed | Prevalence of Phosphodiesterase-5 Inhibitor Use in the VHA in 2004 and 2005 Is Twice That of a Commercial Health Plan in 2001 |
| title_short | Prevalence of Phosphodiesterase-5 Inhibitor Use in the VHA in 2004 and 2005 Is Twice That of a Commercial Health Plan in 2001 |
| title_sort | prevalence of phosphodiesterase-5 inhibitor use in the vha in 2004 and 2005 is twice that of a commercial health plan in 2001 |
| topic | Letters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10438309/ https://www.ncbi.nlm.nih.gov/pubmed/17269850 http://dx.doi.org/10.18553/jmcp.2006.12.8.692 |
| work_keys_str_mv | AT frenchdustind prevalenceofphosphodiesterase5inhibitoruseinthevhain2004and2005istwicethatofacommercialhealthplanin2001 AT margocurtise prevalenceofphosphodiesterase5inhibitoruseinthevhain2004and2005istwicethatofacommercialhealthplanin2001 AT campbellrobertr prevalenceofphosphodiesterase5inhibitoruseinthevhain2004and2005istwicethatofacommercialhealthplanin2001 |